More Business Wire
View Older Stories View Newer Stories-
Ventiva Partners with ASUS to Explore Next-Generation Thermal Architectures for Compact AI Computing Systems
-
FPT and UOB Sign MoU to Advance AI, Technology Transformation and Financial Innovation
-
Mobvista (1860.HK) Delivers Solid 2026 Q1 Performance Fueled by AI-Driven Advertising
-
Best’s Market Segment Report: Japan Life Insurers’ Use of Reinsurance More Than Doubled Since 2020
-
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Total Sales and Shipments of EAI Robots Reached 69 Units in May, a New Record, Exceeding the Combined Total for the Months o
-
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
-
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
-
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
-
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
-
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
-
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
-
BW LPG Enters Into Agreement for Eight 90’cbm Panamax Newbuildings with Hyundai Heavy Industries
-
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
-
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
-
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
-
Global Real Assets Trust Reports Q1 2026 Results
-
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
-
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
-
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
-
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
-
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in P
-
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
-
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
-
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
-
FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million
-
Ferrari Films Issues Formal Rebuttal to Forbes Article Mischaracterizing Section 168(k) as "Worthless" for Film Investors
-
Tanner Introduces New AI Voice Chat Assistant to Reduce Call Center Hold Times
-
KBRA Assigns AA+ Rating to State of Illinois, Build Illinois Bonds (Sales Tax Revenue), Junior Obligation Series A and B of June 2026; Affirms Parity Debt; Stable Outlook
-
Syncora Guarantee Inc. Announces the Availability of Certain Financial Information
-
Republic Technologies Inc. Provides Bi-Weekly Update On Annual Filings
-
$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors
-
Sable Offshore Corp. to Host Conference Call on June 1, 2026
-
SABA Announces Notification of Sources of Distributions
-
BRW Announces Notification of Sources of Distributions
-
Kraken Set to Launch First CFTC-Regulated Perpetual Futures for US Traders
-
Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure
-
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
-
Principal Real Estate Income Fund Announces Notification of Sources of Distribution
-
Fortegra Completes Acquisition by DB Insurance
-
State Street to Speak at the Morgan Stanley U.S. Financials Conference
-
QXO Announces Cash Tender Offers and Consent Solicitations for Any and All of TopBuild Corp.’s 4.125% Senior Notes due 2032 and 5.625% Senior Notes due 2034
-
PGIM Closed-End Funds Declare Distributions for June, July and August 2026
-
Pacific Coast Oil Trust Announces Monthly Net Profits Interest Calculations
-
KKR to Present at the Morgan Stanley US Financials Conference
-
MFS Announces Final Closed-End Fund Distributions and Timing of Reorganization for Certain Funds
-
Essex Property Trust to Present at The 2026 Nareit REITweek Conference
-
Blackstone Credit & Insurance Announces Extension of Reinvestment Period Ahead of May 31, 2027, Scheduled Dissolution Date for Blackstone Senior Floating Rate 2027 Term Fund
-
indie Announces New Employee Inducement Grants
-
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
-
Triumph Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock
